ClinicalTrials.govpublic full text
Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers
healthy, p144, tgf-β1, healthy volunteers, cutaneous tolerability, skin fibrosis, systemic scleroderma, systemic sclerosis, safety, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897199
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.